Clinical Trials
All Clinical Trials - Page 35 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT04371991N/ACompleted
Kisspeptin Levels in Early Pregnancy
Kisspeptin
- NCT03916640Phase 1Completed
A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus
Pramlintide
- NCT03659682Phase 2Unknown
GLP1R in Parkinson's Disease
Semaglutide
- NCT03380806Phase 2Unknown
Prostate Boost Irradiation With Stereotactic Body RT (SBRT)
Gonadorelin
- NCT03590626N/ACompleted
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Dulaglutide
- NCT03812939N/AUnknown
Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated With Long-acting Somatostatin Analogs
Octreotide
- NCT04916665N/ACompleted
Bridging Intestinal Failure With Teduglutide - a Case Report
Teduglutide
- NCT03944434Phase 2Active Not Recruiting
FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer
Gonadorelin
- NCT03959865N/AUnknown
GLP-1 REceptor Agonists and Real World EvIdeNce
Liraglutide
- NCT03541447Phase 2Completed
Tolvaptan-Octreotide LAR Combination in ADPKD
Octreotide
- NCT03867357N/ACompleted
Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia
Gonadorelin
- NCT03712098Phase 2Completed
Daily Liraglutide for Nicotine Dependence
Liraglutide
- NCT03757130Phase 1Completed
Multiple Ascending Dose Study of AMG 598 in Adults With Obesity
Liraglutide
- NCT03746522Phase 3Completed
Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Participants With Moderate to Severe Obesity
Setmelanotide
- NCT03730662Phase 3Completed
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
Tirzepatide
- NCT04190160N/ACompleted
Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)
Liraglutide
- NCT03713684Phase 3Terminated
Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)
Efpeglenatide
- NCT03058939Phase 2Withdrawn
Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer
Gonadorelin
- NCT03057509Phase 1Withdrawn
A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors
Octreotide
- NCT04428684Phase 1Completed
COMPARISON OF A NEW FORMULATION OF GOSERELIN (Pepti 3.6 mg) to Zoladex® 3.6 mg
Gonadorelin
- NCT03740737Phase 3Completed
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1)
Thymosin-Alpha-1
- NCT03574597Phase 3Completed
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity
Semaglutide
- NCT03695237Phase 3Completed
A Study to Evaluate Leuprolide Acetate 45 mg 6-Month Formulation in Children With Central Precocious Puberty (CPP)
Gonadorelin
- NCT03628066Phase 2Completed
Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
Gonadorelin
- NCT03724981Phase 4Completed
A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
Semaglutide
- NCT03707990Phase 1Completed
A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obese
Semaglutide
- NCT03724409EARLY_Phase 1Terminated
Selective Intra-arterial Injection of PRRT in Neuroendocrine Tumor Patients With Liver Metastases
Octreotide
- NCT03702140Phase 2Unknown
Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy
Teriparatide
- NCT03693430Phase 3Completed
Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
Semaglutide
- NCT03819790Phase 4Completed
The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians
Lixisenatide
- NCT03689374Phase 3Completed
A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes
Semaglutide
- NCT03707171Phase 3Completed
Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus
Liraglutide
- NCT03993132N/ACompleted
A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes
Liraglutide
- NCT03720886Phase 1/Phase 2Unknown
G56W1 in Women With Postmenopausal Osteoporosis
Teriparatide
- NCT03756116N/AUnknown
Effect of Papillary Epinephrine Spraying for the Prevention of Post-ERCP Pancreatitis in Patients Received Octreotide
Octreotide
- NCT03480022Phase 3Completed
Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
Liraglutide
- NCT03684642Phase 3Terminated
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
Dulaglutide
- NCT03678025Phase 3Recruiting
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Gonadorelin
- NCT03422666Phase 2/Phase 3Completed
Plasma Lipoprotein Response to Glucagon-like Peptide-2
Teduglutide
- NCT03710889Phase 3Completed
Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption
Abaloparatide
- NCT03641560Phase 4Completed
A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy
Gonadorelin
- NCT03672604Phase 1Completed
A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects
Exenatide
- NCT03624517Phase 4Terminated
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
Octreotide
- NCT04671966Phase 4Unknown
Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction
Gonadorelin
- NCT03631186N/ACompleted
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND)
Semaglutide
- NCT03664895Phase 3Unknown
Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)
Gonadorelin
- NCT02913859Phase 2Unknown
Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer
Gonadorelin
- NCT03671733Phase 3Unknown
Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients
Liraglutide
- NCT03672812Phase 3Completed
The Use of Liraglutide in Brain Death
Liraglutide
- NCT03260881Phase 4Completed
Liraglutide Effects on Epicardial Fat Inflammatory Genes
Liraglutide